An online application for storing, analyzing, and sharing dermatological data

Tóth, János; Bartha, L.; Szabó, Tamás; Lázár, István; Harangi, Balázs; Hajdú, András

doi:10.1109/coginfocom.2015.7390615

Cited by 3 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5 Such efficiency improvements promise to free up time for personal development among health care professionals and the evolvement of the physician's role. 12,29 Shared databases for dermatologic ML-HCA images 30 could help coordinate collaboration across indications and enable coownership of intellectual medical progress. This might further increase ML-HCA-related benefits, especially for rare diseases.…”

Section: Non-imaging Datamentioning

confidence: 99%

See 1 more Smart Citation

Risks and benefits of dermatological machine learning health care applications—an overview and ethical analysis

Willem

Krammer

Böhm

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background Visual data are particularly amenable for machine learning techniques. With clinical photography established for skin surveillance and documentation purposes as well as progress checks, dermatology is an ideal field for the development and application of emerging machine learning health care applications (ML-HCAs). To date, several ML-HCAs have detected malignant skin lesions on par with experts or found overlooked visual patterns that correlate with certain dermatological diseases. However, it is well established that ML-HCAs come with ethical and social implications.Objectives Currently, there is a lack of research that establishes model design, training, usage and regulation of such technologies sufficient to ensure ethically and socially responsible development and clinical translation, specifically within the field of dermatology. With this paper, we aim to give an overview of currently discussed ethical issues relating to dermatological ML-HCAs.Methods On the basis of a thematic, keyword-based literature search, we performed an ethical analysis against established frameworks of biomedical ethics. We combined our results with current, relevant normative machine learning ethics literature to identify the status quo of the ethics of ML-HCAs in dermatology. We describe the benefits and risks of dermatological ML-HCAs that are currently being developed for clinical purposes. ResultsThe potential benefits range from better patient outcomes to better knowledge accessibility to decreasing health care disparities, that is, standards of care between different population groups. The risks associated with ML-HCAs range from confidentiality issues to individual patient outcomes as well as the exacerbation of prevalent health care disparities. We discuss the practical implications for all stages of dermatological ML-HCA development. ConclusionWe found that ML-HCAs present stakeholder-specific risks for patients, health care professionals and society, which need to be considered separately. The discipline lacks sufficient biomedical ethics research that could standardize the approach to ML-HCA model design, training, use and regulation of such technologies.

show abstract

Section: Non-imaging Datamentioning

confidence: 99%

“…Shared databases for dermatologic ML‐HCA images 30 could help coordinate collaboration across indications and enable co‐ownership of intellectual medical progress. This might further increase ML‐HCA‐related benefits, especially for rare diseases 12,31,32 …”

Section: Potential Benefits Of Ml‐hcas For Dermatologymentioning

confidence: 99%